Archives: May 2015

Alexion Pharmaceuticals purchases Synageva BioPharma Corp – May 12, 2015

In a cash-and-stock deal valued at more than AUD$10.5 billion, Alexion Pharmaceuticals purchased orphan drug biopharma manufacturing company, Synageva BioPharma Corp on Wednesday, May 6, 2015. Synageva is currently awaiting approval from the US Food and Drugs Administration (FDA) and the European Medicines Agency (EMA), of its first orphan treatment....

read more